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Epidemiological and clinical studies have shown that children exposed to adverse expe-
riences are at increased risk for the development of depression, anxiety disorders, and
posttraumatic stress disorder (PTSD). A history of child abuse and maltreatment increases
the likelihood of being subsequently exposed to traumatic events or of developing PTSD
as an adult. The brain is highly plastic during early life and encodes acquired information
into lasting memories that normally subserve adaptation. Translational studies in rodents
showed that enduring sensitization of neuronal and neuroendocrine circuits in response
to early life adversity are likely risk factors of life time vulnerability to stress. Hereby, the
hypothalamic-pituitary-adrenal (HPA) axis integrates cognitive, behavioral, and emotional
responses to early-life stress and can be epigenetically programed during sensitive win-
dows of development. Epigenetic mechanisms, comprising reciprocal regulation of chro-
matin structure and DNA methylation, are important to establish and maintain sustained,
yet potentially reversible, changes in gene transcription.The relevance of these findings for
the development of PTSD requires further studies in humans where experience-dependent
epigenetic programing can additionally depend on genetic variation in the underlying sub-
strates which may protect from or advance disease development. Overall, identification
of early-life stress-associated epigenetic risk markers informing on previous stress his-
tory can help to advance early diagnosis, personalized prevention, and timely therapeutic
interventions, thus reducing long-term social and health costs.
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INTRODUCTION
The overall burden of mental disorders – individual, societal, and
economic – has been increasing in recent decades (1) and is greater
than 10 years ago despite the availability of reasonably effec-
tive pharmacological and psychological interventions (2). Among
mental disease posttraumatic stress disorder (PTSD) is a debil-
itating stress-related disease with prevalence rates amounting to
8%, and considerable higher rates among those living in high-
violence areas and combat veterans (3–5). Originally thought of as
a normative response to trauma, epidemiological studies showed
that exposed subjects differed with respect to their later on risk
for developing PTSD (6). This finding led to intense investiga-
tions to identify genetic and environmental factors associated with
the onset, course, and treatment response of this disease. Overall,
epidemiological and clinical studies have provided compelling evi-
dence for a strong association between various forms of early life
adversity, depression, and PTSD (Figure 1).
For this reason, we will refer the reader to the role of early life
adversity for the development of depression whenever correspond-
ing findings in PTSD are not available. This applies in particular to
the role of experience-dependent epigenetic programing which is
increasingly recognized as a mechanism in depression (7, 8). More-
over, given the central role of the hypothalamic-pituitary-adrenal
(HPA) stress axis in response to early life adversity we will focus on
its deregulation in both depression and PTSD. While PTSD and
depression represent distinct entities, such a comparative approach
can provide a conceptual framework for future studies in PTSD.
According to the National Comorbidity Survey Replication (9)
early life adversity comprises interpersonal loss (parental death,
parental divorce, and other separation from parents or caregivers),
parental maladjustment (mental illness, substance abuse, crimi-
nality, and violence), maltreatment (physical abuse, sexual abuse,
and neglect), life-threatening childhood physical illness in the
respondent, and extreme childhood family economic adversity.
A landmark survey conducted at the Center for Disease Control
showed a strong dose-response relationship between childhood
adversities and mental health problems in adulthood (10). Patients
suffering from major depression showed a fourfold increased
risk for depression following multiple adverse exposures (11), a
dose-response relationship between the severity of experienced
childhood adversities and lifetime recurrent depression (12) and
a twofold to fivefold increase in attempted suicide in up-growing
children, adolescents, or later adults (13). These data corroborate
with other representative surveys such as the National Comorbid-
ity Survey (14), the Ontario Health Survey (15, 16), and the New
Zealand Community Survey (17).
Similarly, individuals who were exposed to early life adversity
are also more likely to develop PTSD (18, 19), to face re-exposure
to trauma in adulthood, and to suffer from PTSD following trauma
in adulthood (20–22) (Figure 1).
Hence, early life adversity is a powerful risk factor for mental
diseases such as depression and PTSD and can predict a prolonged
course and poorer response to treatment. The high incidence of
child maltreatment represents an epidemic health problem and the
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FIGURE 1 | Model for the role of early-life adversity for PTSD and
depression. In the absence of a history of early life adversity (ELA), adults
can be resilient to disease upon exposure to severe trauma and stress (A)
while others will develop PTSD or depression (B). Similarly, not all children
exposed to early life adversity will develop disease upon anew exposure to
trauma and stress (C). On the other hand, exposure to early life adversity in
childhood can give rise to a vulnerable phenotype predisposing to disease
upon anew exposure to trauma and stress (D).
long-term consequences of such trauma place a heavy burden on
the healthcare system and society (23). According to the National
Center of Child Abuse and Neglect approximately 3.4 million
referrals, comprising alleged maltreatment of approximately 6.2
million children, were received across the US in 2011 (24). One-
fifth of these children were found to be victims with disposition of
substantiated (18.5%), indicated (1.0%), and alternative response
victim (0.5%). All in all 676,569 victims of child abuse and neglect
give rise to a unique victim rate of 9.1 victims per 1,000 children
in the US population:
• more than 75% (78.5%) suffered neglect
• more than 15% (17.6%) suffered physical abuse
• less than 10% (9.1%) suffered sexual abuse
• more than four children (1,570 fatalities) died daily
These numbers recapitulated by and large prior findings (10,
25–28). Despite this compelling evidence for a link between
early neglect, abuse, and later psychopathology (9, 29) knowledge
about the molecular mechanisms underlying the long-term mental
health consequences remains poor (30).
THE VULNERABLE BRAIN
Early brain development is a time of great opportunities and
great vulnerabilities. The architecture of the developing brain is
constructed through an ongoing process that begins before birth
and extends into adulthood. Brain development and architecture
are built from the bottom up with simple structures providing
the scaffold for the formation of more advanced structures over
time. Research in the field of neuroscience has provided com-
pelling evidence for the high plasticity of the developing brain as
a function of experience which allows encoding of acquired infor-
mation into lasting memories that normally subserve adaptation
(31, 32). Sensitive periods refer to time windows during which
developmental cues induce lasting programmable and organiza-
tional effects on neuronal substrates. Early adverse experiences
in rodents and higher primates such as prenatal maternal stress,
maternal separation,variable foraging demand,or naturally occur-
ring low maternal care can lead to structural and functional
changes in a connected network of brain regions implicated in neu-
roendocrine control, autonomic regulation, and vigilance (33–36).
These neural changes converge on lifelong increased physiological
and behavioral responses to subsequent stress (37). Ultimately, the
enduring effects of early life adversity on the brain and its regula-
tory outflow systems, comprising the autonomic, endocrine, and
immune systems, may lead to the development of a vulnerable
phenotype with increased sensitivity to stress and risk for a range
of somatic (38–40) and behavioral disorders (i.e., depression and
PTSD) (9).
THE CENTRAL ROLE OF THE HPA AXIS
Early life adversity can cause lasting structural and regulatory
adaptations in the neuroendocrine system predisposing to or pro-
tecting from stress-related diseases later in life (41–43). Initial
studies on PTSD focused on the HPA axis due to its central position
in the neuroendocrine stress response (Figure 2). The two neu-
ropeptides corticotrophin-releasing hormone (CRH) and arginine
vasopressin (AVP) are secreted by the parvocellular neurons of
the hypothalamic paraventricular nucleus (PVNh) and coordi-
nate the behavioral and metabolic responses to stress. Binding to
G-protein coupled receptors at the anterior pituitary gland induces
co-operatively pro-opiomelanocortin (POMC) which is processed
to adrenocorticotrophin (ACTH), opioid, and melanocortin pep-
tides among others. Subsequently, ACTH stimulates the adrenal
cortex to secrete cortisol (in humans) and corticosterone (in
humans, rats, and mice). Corticosteroids activate ligand-gated glu-
cocorticoid (GR) and mineralocorticoid (MR) receptors which are
coexpressed in neurons of limbic structures. High levels of GR are
additionally detected in the PVNh and the anterior pituitary. The
MR is thought to serve in the assessment and onset of the stress
response whereas GR,requiring higher amounts of glucocorticoids
for activation, terminates the stress reaction (44).
In contrast to the PVNh, CRH neurons in the central nucleus
of the amygdala project to the locus coeruleus and enhance the
firing rate of its neurons resulting in increased noradrenaline
release in the vast terminal fields of the ascending noradrener-
gic system (45). One of the principal noradrenergic targets are the
CRH neurons of the PVNh, which respond to increased activity
in the nucleus tractus solitarius, the dorsal medullary nucleus, and
the locus coeruleus (46). Experimental lesions of these regions
result in a significant decrease in stress-induced PVNh levels of
noradrenaline, reduced plasma ACTH responses, and behavioral
responses to stress (47, 48). In sum, CRH neurons in the PVNh
and the central nucleus of the amygdala jointly mediate behavioral
and endocrine responses to stress.
Although commonly adaptive, sustained activation of these
stress circuits results in impairments. Elevated central CRH activ-
ity is associated with symptoms of anxiety and depression. This
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FIGURE 2 |The hypothalamic-pituitary-adrenal axis integrates and
mediates the stress response to early life and later on adversity. The
perception of real and/or presumed physical and social threats causes
activation of the hypothalamic-pituitary-adrenal axis. Anxious states arise
from activation of the amygdala and magnify the stress response via
neuronal projections to the paraventricular nucleus (PVN). The hippocampus
plays an important role in the assessment of stressors and as a site of
glucocorticoid receptor (GR) mediated negative feedback regulation.
Release of the hypothalamic neuropeptides corticotrophin-releasing
hormone (CRH) and arginine vasopressin (AVP) promotes the synthesis and
secretion of adrenocorticotrophin (ACTH), a posttranslational cleavage
product of anterior pituitary pro-opiomelanocortin mRNA (POMC). ACTH in
turn stimulates the release of glucocorticoids from the adrenal glands.
These hormones circulate throughout the whole body and the brain and bind
to intracellular nuclear steroid receptors. Hippocampal mineralocorticoid
(MR) receptors act to the onset of the stress response, while GR at the
hippocampus, PVN, and anterior pituitary terminates the stress response.
The GR further transactivates FKBP51 encoding a chaperon protein which
curtails GR activity through a fast intracellular negative feedback loop.
is most likely due to the CRH-induced stimulation of sero-
tonergic and noradrenergic systems (49). Glucocorticoids and
catecholamines enhance learning for information related to the
stressor (50) whereas glucocorticoids impair attention and learn-
ing in relation to events not directly associated with the stressor
(37). Additionally, glucocorticoids facilitate the behavioral effects
of central Crh partly due to the upregulation of Crh in the central
nucleus of the amygdala (51, 52).
LONG-TERM EFFECTS OF EARLY-LIFE ADVERSITY
In rodents and higher primates early-life stress lastingly influ-
ences the development of the central CRH systems underlying the
expression of behavioral, emotional, autonomic, and endocrine
responses to stress later in life (53, 54). Major depression frequently
shows signs of a disinhibited HPA axis due to an increased parvo-
cellular CRH expression which drives production and secretion of
pituitary ACTH and subsequently cortisol (Table 1). CRH over-
expression reflects an impaired negative GR feedback regulation
as evidenced by a reduced inhibition of cortisol secretion after
application of the synthetic glucocorticoid dexamethasone (55)
(Table 1).
Notably, depressed patients with a history of early child adver-
sity were shown to differ in their neuroendocrine regulation.
Although they shared signs of a hyperactive HPA axis, plasma
cortisol is unaltered or reduced in part of these patients (Table 1).
Moreover, their response to psychotherapy alone appeared supe-
rior to antidepressant therapy when compared to patients without
a history of early child adversity (56).
Adult PTSD patients show a distinct neuroendocrine profile
characterized by centrally elevated CRH, low plasma cortisol, and
enhanced suppression of plasma cortisol and ACTH following the
dexamethasone suppression test (Table 2). An increased respon-
siveness of both peripheral and central GR has been suggested as
a plausible cause for hypocortisolemia (Table 2).
While hypocortisolemia in depressed patients is confined to
those with a history of early life adversity (Table 1, right), PTSD
patients are affected in either case (Table 2, left). This raises the
question of whether hypocortisolemia precedes trauma exposure
or whether it is a long-term consequence thereof promoting the
manifestation of either depression or PTSD.
In this regard, longitudinal studies have shed some light on the
development of HPA-axis deregulation in traumatized children.
From an early age on, maltreatment, neglect, physical, and sex-
ual abuse manifest with low levels of cortisol which persist into
adulthood (Table 2, right). Furthermore, abused children dis-
play flattened diurnal cortisol levels (57) and increased cortisol
suppression after administration of dexamethasone (58). These
results corroborate the concept of an enhanced GR response
and negative feedback function. However, sexually abused girls
initially showed higher levels of cortisol after trauma expo-
sure. Hypercortisolemia decreased, however, during growing up
and cortisol remained low in young adults when compared to
their unabused peers (59). A similar cortisol pattern has been
detected in pediatric patients who experienced motor vehicle
accidents and developed PTSD at 6 months. Initially, they had
high levels of cortisol which passed over into hypocortisolemia
at 6 months (60). Taken together, these findings suggest that
trauma exposure associates with an acute stress response followed
by hypocortisolemia and GR hyperresponsiveness in vulnerable
subjects. This raises the important question of whether hypocor-
tisolism precedes clinical manifestation of PTSD and thus rep-
resents a potential marker for later on risk for illness (Table 2).
In this respect, longitudinal studies identified low levels of cor-
tisol as a risk factor to develop PTSD after trauma exposure
(61–63).
In conclusion, neuroendocrine findings in PTSD and individ-
uals exposed to early life adversity indicate that hypocortisolemia
per se does not result in PTSD but seems to increase the risk to
develop disease following additional trauma exposure. The cel-
lular and molecular mechanisms causing hypocortisolemia due
to enduring deregulation of the HPA axis and how they interact
with later on trauma to manifest as PTSD are presently largely
unknown.
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Table 1 | Neuroendocrine status in depressed patients without and with a history of early life adversity.
MD Reference MD+ELA Reference
CRH ↑ Nemeroff et al. (139) ↑ Carpenter et al. (140)
↑ Raadsheer et al. (141)
↑ Wang et al. (142)
Cortisol ↑ Sachar et al. (143) ↓ Shea et al. (144)
↑ Holsboer et al. (145) ↓ Heim et al. (146)
↑ Holsboer et al. (147) ↑ Gerra et al. (148)
↑ Wingenfeld et al. (149) = Heim et al. (150)
↑ Carvalho Fernando et al. (151) ↑ Power et al. (152)
↑ Hinkelmann et al. (153)
↑ Messerli-Bürgy et al. (154)
↑ Yilmaz et al. (155)
DST Cortisol ↑ Carroll et al. (156) ACTH↓ cortisol ↓ Newport et al. (157)
ACTH ↑ cortisol ↑ Modell et al. (158)
Cortisol ↑ Carvalho Fernando et al. (151)
CST ACTH ↑ Holsboer et al. (147) ACTH ↓ cortisol ↓ Heim et al. (146)
ACTH ↓ Heim et al. (146) Cortisol ↑ Heim et al. (150)
MD, major depression; ELA, early life adversity; DST, dexamethasone suppression test; CST, corticotrophin-releasing hormone stimulation test; ACTH, adrenocorti-
cotrophin hormone.
In the following parts, we will explore the possibility of epige-
netic mechanisms to encode traumatic experiences. We will further
argue that insight from experience-dependent epigenetic pro-
graming by early-life adversity in depression can serve as guidance
to advance translational studies in PTSD.
A GUIDE TO DNA METHYLATION
The epigenetic landscape has unfolded at multiple layers involving
DNA methylation, histone modifications, non-coding RNA, and
nucleosome positioning; along with DNA sequence. For the pur-
pose of this review we will consider only the former two and refer
the interested reader to recent reviews (64–66).
As a stable, though potentially reversible, repressive mark, DNA
methylation is considered to represent an important player in epi-
genetic control of transcription (67). DNA methylation is carried
out by a family of DNA methyltransferases (DNMTs) comprising
DNMT1, DNMT3A, DNMT3B, and DNMT3L. DNMT1 primarily
methylates hemimethylated DNA in vitro and is recruited to repli-
cation foci during S phase, while DNMT3A and DNMT3B prefer-
entially recognize unmethylated CpG dinucleotides and regulate
de novo methylation during development.
Specific histone modifications and DNA methylation recipro-
cally influence each other in deposition (Figure 3). Mechanis-
tically, components of the histone methylation system associate
physically with one or more DNMTs. For example, trimethylation
of H3K9, H3K27, and H4K20 emerged as a prerequisite for sub-
sequent DNA methylation. The methyltransferases SUV39H1/2
and EZH2 catalyzing H3K9 and H3K27 methylation, respectively,
bind directly to DNMT1, DNMT3A, or DNMT3B and facilitate
their recruitment to target loci (68, 69). Similarly, the recruit-
ment of HP1 (heterochromatin protein 1) to constitutive hete-
rochromatin results from SUV39H1/2-mediated trimethylation of
H3K9 while euchromatin binding depends on dimethylation cat-
alyzed by the histone methyltransferase G9A (70). Once bound,
HP1 can directly interact with DNMT3A to guide DNA methyla-
tion (71). Conversely, histone methylation can also interfere with
DNA methylation. DNMT3L, lacking catalytic activity, specifi-
cally recognizes the extreme amino terminus of the core histone
H3 in a methylation sensitive manner. Methylation of H3K4 but
not of other residues blocks interaction with DNMT3L and the
subsequent recruitment of DNMT3A2 (72).
Taken together, histone methylation can both facilitate and
impair the recruitment of DNMTs and intermediary factors
in a context dependent manner to impose changes in DNA
methylation and the long-term control of gene activity (Figure 3).
The globally methylated, CpG poor genomic landscape is punc-
tuated by CpG islands (CGIs). Approximately 70% of all annotated
gene promoters are associated with a CGI that are typically free of
DNA methylation (73). In mammals tissue- and cell type-specific
DNA methylation is detected in a small percentage of 5′ CGI
promoters whereas most DNA methylation occurs in intra- or
inter-genic regions which unexpectedly correlates with increased
rather than decreased transcription (74–76) or alternatively with
elective promoter usage (77).
Active DNA demethylation in mammals remains presently sub-
ject of intense investigation as cytosine deamination, oxidation,
and base excision repair enzymes have been suggested in a variety
of combinations (78).
A second, more recently discovered mechanism implicates the
actions of ten eleven translocation (TET) proteins which con-
vert 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) by
an oxygen-, and α-ketoglutarate-dependent mechanism, then to
5-formylcytosine and hereafter to 5-carboxycytosine (79). This
modified residue is excised by glycosylases to be replaced by
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Table 2 | Neuroendocrine status in PTSD patients without and with a history of early life adversity and in healthy controls exposed to early life
adversity.
PTSD Reference ELA Reference
CRH ↑ Bremner et al. (159) ↑ Lee et al. (160)
↑ Baker et al. (161)
↑ de Kloet et al. (162)
Cortisol ↑→ ↓ Ch Pervanidou et al. (60) ↓ Ch Carlson and Earls (163)
↓ ELA Bremner et al. (164) ↓ Ch King et al. (165)
↓ ELA Brand et al. (166) ↓ Ch Kliewer (167)
↓ Yehuda et al. (168) ↓ Ch Bevans et al. (169)
↓ Boscarino (170) ↓ Ch Badanes et al. (171)
↓ Yehuda et al. (172) ↓ Ch Hauser et al. (173)
↓ Thaller et al. (174) ≈Ch Bruce et al. (57)
↓ Rohleder et al. (175) ↑ Ch→ ↓ Trickett et al. (59)
↓ Bierer et al. (176) ↓ Resnick et al. (61)
↓ Brand et al. (177) ↓ Brewer-Smyth and Burgess (178)
↓ Wingenfeld et al. (149) ↓ Flory et al. (179)
↓ RF Resnick et al. (61) ↓ Power et al. (152)
↓ RF McFarlane et al. (62) ≈Ad Weissbecker et al. (180)
↓ RF Delahanty et al. (63) ≈Ad van der Vegt et al. (181)
GR-r ↑ Yehuda et al. (182) ↑ Heim et al. (146)
↑ Yehuda et al. (183)
↑ Yehuda et al. (184)
DST Cortisol ↓ Yehuda et al. (183) Cortisol ↓ Ch Goenjian et al. (58)
ACTH↓ ELA Duval et al. (185) Cortisol ↓ Stein et al. (186)
ACTH↓ cortisol↓ Yehuda et al. (187) Cortisol ↓ Heim et al. (188)
ACTH↓ Ströhle et al. (189)
CST ACTH↓ cortisol↓ Ströhle et al. (189) Cortisol ↑ Heim et al. (188)
Cortisol ↓ Carpenter et al. (190)
ACTH ↑ Heim et al. (146)
PTSD, posttraumatic stress disorder; ELA, early life adversity; GR-r, glucocorticoid receptor reactivity; DST, dexamethasone suppression test; CST, corticotrophin-
releasing hormone stimulation test; ACTH, adrenocorticotrophin hormone. Indices are; RF, risk factor for PTSD; Ch, children; ≈Ch or ≈Ad, flattened diurnal cortisol
in children or adults.
cytosine via the base repair system (80). Interestingly, hydrox-
ymethylation can be selectively recognized by DNA-binding pro-
teins raising the prospect that it serves a biological function on
its own (81). For example, Mbd3 preferentially binds to 5-hmC
relative to 5-methylcytosine to confer gene repression (82).
In sum, DNA methylation occurs at different gene regulatory
regions controlling transcription, alternative promoter usage, and
splicing. Methylation of CpG residues is a stable though potentially
reversible mark catalyzed by enzymatic conversion.
AN EPIGENETIC ARCHIVE
The “DNA ticketing theory of memory” was proposed some
40 years ago by Griffith and Mahler to account for the extraor-
dinary persistence of memory (83). Given that “nerve cells do
not normally divide in adult life and their DNA is generally con-
sidered to be metabolically stable” they hypothesized that “the
physical basis of memory could lie in the enzymatic modification
of the DNA of nerve cells” whereby “the modification consists of
methylation (or demethylation).” This concept has been reviewed
by Holliday who proposed that “the initial signal which is to be
memorized, switches the DNA from a modified to an unmodified
state, or vice versa;” thereby, “demethylation is a more likely pos-
sibility since from existing evidence this may activate a gene” (84).
This hypothesis has been largely ignored because DNA methyla-
tion was originally thought of as part of a stable, epigenetic cellular
memory system that controls gene silencing via chromatin struc-
ture. Hence, postmitotic cells were considered to be refractory to
any changes in DNA methylation. Recent reports suggest, however,
that DNA methylation is also involved in controlling the dynamics
and plasticity of gene regulation, particularly during differentia-
tion (85). Moreover, DNA methylation in postmitotic neurons can
respond to social experiences and encode lasting changes in gene
expression (86). In this regard, experience-dependent DNA mem-
ories can be described as the sequential process of a social and/or
physical event registered by sensory and cognitive brain areas. The
subsequent activation of intracellular signaling pathways, coupled
to the epigenetic machinery, and ultimately its recruitment to spe-
cific gene loci, enables to erase, establish, and maintain epigenetic
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FIGURE 3 | A (simplified) guide to DNA methylation. (A) Approximate
147 bp of DNA are wrapped around the nucleosome which is made up by the
core histones H2A, H2B, H3, and H4. The free ends of the histone tails serve
as substrate for posttranslational modifications (e.g., acetylation,
phosphorylation, and methylation) that influence the configuration of
chromatin. Opened states (euchromatin) allow transcription while closed
states (heterochromatin) restrict the transcriptional machinery. (B)
Euchromatin is characterized by acetylation and phosphorylation (green
triangles) whereas methylation (yellow circles) is more often found at
heterochromatin. Specific histone modifications and DNA methylation
reciprocally influence each other in deposition. For example, histone
methylation at H3K9, H3K27, and H4K20 promotes DNA methylation at CpG
dinucleotides. This covalent modification refers to the transfer of methyl group
to cytosine resides at gene regulatory regions. Hypermethylation typically
links to lasting transcriptional repression while hypomethylation favors gene
expression.
marks. Admittedly, not all examples of early-life stress-dependent
changes in DNA methylation can satisfy these criteria (7).
For the purpose of this review, we will focus on those genes of
the HPA axis known to be lastingly deregulated in both depression
and PTSD and ask whether epigenetic programing contributes to
these processes. Experience-dependent programing of the HPA
axis has been intensively studied in rodents and examples given
below serve to illustrate the overarching concept without attempt-
ing to provide a comprehensive survey of this field. In considering
epigenetic programing of key regulators of the HPA axis,a develop-
mental perspective (i.e., embryonic, prenatal, postnatal, and adult
stages) is adopted whenever possible to illustrate that the brain is
susceptible to epigenetic programing across the entire life span.
EXPERIENCE-DEPENDENT PROGRAMING OF CRH
Parvocellular hypothalamic CRH-expressing neurons participate
both in the peripheral and central stress systems by governing
secretion of ACTH from the pituitary contributing to the periph-
eral, neuroendocrine stress response, and by modulating stress-
related behavior including anxiety as well as learning and memory.
The CRH peptide is additionally detected in neocortex and in
limbic regions including the central nucleus of the amygdala, the
dorsal and ventral part of the bed nucleus of the stria terminalis,
and the hippocampus. Further sites comprise the locus coeruleus,
dorsal and median raphe, periaqueductal gray, nucleus of the soli-
tary tract, and cerebellar complex. For the purpose of this review,
we will focus in the following section largely on stress-dependent
programing of Crh in the PVNh.
Early-life experience can evoke lasting changes in Crh expres-
sion levels in the PVNh as evidenced by several paradigms
comprising onetime or repeated separation from the mother for
up to 24 h, manipulation of maternal behavior by “handling” and
limiting nesting materials for the dam during the first weeks of
life. In this respect, maternal separation for 24 h has been doc-
umented to either not influence (87) or reduce basal Crh gene
expression in rat (88) and mice PVNh (89). Of note, prolonged
maternal separation for 8 h leads to desensitization of the HPA
axis with reduced corticosterone after replication of prolonged
maternal separation (90, 91). In response to acute stress, maternal
deprivation leads, however, to higher transcription of the Crh gene
and rapid secretion of ACTH and glucocorticoids (87, 92–94).
Enhanced maternal care due to natural variation (95, 96)
reduces Crh expression in the PVNh in the adult offspring, cur-
tails hormonal responses to stress, and enhances hippocampal GR
levels. Similarly, daily brief (15 min) separations from the mother
during postnatal week 1 up to 3 promotes an adult phenotype
characterized by a sensitization of the HPA axis with an attenuated
stress response (33, 97) associated with reduced basal expression
of Crh in the PVNh and increased hippocampal expression of the
GR (98, 99). Hereby, the reduction of Crh expression in the PVNh
precedes further changes at different levels of the HPA axis com-
patible with the idea that Crh mediates handling-evoked maternal
care to adaptation of the HPA axis (99, 100).
Sustained early-life stress can also be generated by limiting the
amount of nesting material which creates an enduring stressor for
the dam. This leads to fragmented maternal care and imposes an
additional stressor on the pups (101, 102). By the end of 1 week
of postnatal stress (P9), Crh mRNA expression in the PVNh of
the early-life stress group is significantly reduced compared to
undisturbed controls (102). Reduced Crh expression may reflect
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altered glucocorticoid negative feedback and/or increased Crh
release concomitant with a failure of acute stress-induced Crh
production.
Collectively, these exemplary studies in rodents illustrate that
early trauma and stress can cause sustained changes in Crh expres-
sion which critically depend on the developmental stage of the
limbic-HPA axis. Are then any of these changes in Crh expression
related to epigenetic mechanisms such as DNA methylation?
EPIGENETIC PROGRAMING OF Crh
The fetus grows up in the womb protected by the placental bar-
rier which shields from any adversity that might arise in the
maternal environment. Severe stressors and strains can, however,
compromise the placental barrier and expose the developing fetal
brain to maternally derived substances, such as cytokines or stress
hormones. The latter can trigger increased vulnerability to depres-
sion, anxiety, schizophrenia, and autism (103). In this respect,
male but not female mice offspring exposed to chronic variable
stress early in gestation (embryonic day 1–7) displayed impaired
behavioral stress responsivity, anhedonia, and an increased sen-
sitivity to treatment with a selective serotonin reuptake inhibitor
(104). Increased Crh expression in the amygdala is associated with
decreased promoter methylation (Figure 4), while decreased GR
expression in the dorsal hippocampus correlated with increased
methylation at the NGFI-A binding site of exon 17 (see below).
Notably, the fetal brain was unformed at the time the stressor was
applied to the mother indicating that sex-specific changes in fetal
development and long-term adaptation of the HPA axis might
be mediated through effects on the developing placenta. In this
regard, male control placentas showed lower Dnmt1 expression
compared to females. Moreover, increases in placental Dnmt1 in
response to prenatal stress were largely confined to females. How
increased Dnmt1 expression might counteract prenatal stress-
dependent perturbations in placental gene expression remains
presently unknown.
In a postnatal study, rats exposed to early-life stress (maternal
separation) were studied for HPA-axis responses to acute restraint
stress and Crh promoter methylation in the PVNh nucleus and
the central nucleus of the amygdala (105). Despite slightly lower
plasma ACTH, plasma corticosterone levels in female rats sub-
jected to early-life stress were significantly higher in basal condi-
tions and after exposure to acute restraint stress. In males, early-life
stress did not affect basal plasma corticosterone levels, but in
females the increases after restraint were significantly higher in
early-life stressed males than in controls. In accord with these
findings, Crh mRNA expression in the PVNh was increased under
resting and acute stress conditions in females while increases in
males occurred only under acute stress conditions (Figure 4).
Moreover, Crh expression in the central amygdala was unaffected
in either condition in both sexes. Early-life stress associated with
hypomethylation of the Crh promoter in the PVNh in either sex
and mapped to two CpG residues localized next to and at the
dyad symmetry axis of a cyclic AMP responsive element (CRE).
Methylation of the latter CpG residue impaired DNA binding of
the activated form of the CRE binding protein (p-CREB) compat-
ible with the idea that early-life stressed induced hypomethylation
FIGURE 4 | Experience-dependent epigenetic programing of Crh.
Prenatal, postnatal, and adult mice or rats were exposed to different
stress paradigms (chronic variable, maternal separation, or social intruder
stress). Sexes are indicated by respective symbols. Results from Crh
promoter methylation and expression are depicted for the
paraventricular nucleus (PVN) and the central amygdala (CeA). Tissues
were isolated under resting conditions or following application of an
acute stressor. Arrows show increased, decreased, and unaltered CpG
methylation and Crh mRNA expression, respectively, for the indicated
brain regions. Non-determined (n.d.) refers to the absence of
information. In sum, epigenetic programing of Crh occurs in a stressor-,
sex-, and tissue-specific manner.
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facilitates CREB binding and subsequently basal and activated Crh
transcription.
Exposure to social defeat over 10 consecutive days imposes sus-
tained social stress on adult male mice resulting in anhedonia
and social avoidance. This well-known paradigm associated with
demethylation at the proximal Crh promoter (106). As a result,
Crh mRNA expression in the PVNh was significantly increased
(Figure 4). Interestingly, Crh demethylation was confined to males
displaying signs of stress while those being unaffected escaped
demethylation and Crh overexpression. Given that genetically
homogenous mice were housed and tested under standardized
operating procedures this differential response suggests that sub-
tle differences in the previous life histories can modify the outcome
from exposure to stress. Application of imipramine over 3 weeks,
a clinically relevant time period, improved the social avoidance
behavior and reversed changes in Crh promoter methylation and
gene expression. Crh demethylation was preceded by decreases in
Dnmt3b and Hdac2 expression, while Gadd45b expression was
temporarily increased. In this regard, Gadd45b has been shown
to subserve demethylation by facilitating recruitment of the DNA
repair machinery (107, 108).
In a further study, adult male and female rats were exposed
to chronic variable stress after which Crh expression and pro-
moter methylation was measured in the PVNh, the bed nucleus
of the stria terminalis and the central amygdala (109). Chronic
variable stress produced Crh promoter hypermethylation at spe-
cific CpG dinucleotides in all tissues examined in females while
the effects in males were confined to the stria terminalis and the
central amygdala. In the PVNh, chronic variable stress increased
Crh expression in the males (in the absence of changes in methyla-
tion), while the Crh peptide decreased in females most likely due to
increased promoter methylation (Figure 4). This study firstly evi-
denced sex-specific epigenetic programing of Crh and illustrates
the importance of sex differences in brain epigenetics (110). The
functional implications of decreased Crh expression in females in
the presence of elevated corticosterone levels requires, however,
further investigations.
Together, these studies show that epigenetic programing of Crh
can occur in a stressor-, tissue-, and sex-specific manner. Moreover,
differences in the previous life history might protect from epige-
netic programing. Subsequent variations in DNA methylation at
the Crh gene can serve to distinguish the transcriptional response
to later stress-related stimuli. Experience-dependent programing
of gene expression potential can thus confer an increased risk
to anewed stress exposure and the manifestation of stress-related
diseases such as depression and PTSD (Figure 5).
EXPERIENCE-DEPENDENT PROGRAMING OF Avp
Newborn rats exposed to repeated brief maternal separation and
handling (PND 1–10) showed as adults reduced social investigative
interactions and increased aggressive behavior with a higher fre-
quency of attacks in the social interaction test. The latter behavior
was detected only in males which displayed an increased number
of Avp-positive magnocellular neurons in the PVN (111).
A related phenotype was detected following maternal separa-
tion in mice (112). While both sexes displayed increased anxiety-
related behavior (reduced time spent on open arms in the elevated
FIGURE 5 | Model for epigenetic risk factors in PTSD and depression.
Genetic mutations (red segment of the DNA double helix) can confer an
increased vulnerability to PTSD and depression which manifest following
anew exposure to stressful life events (red flash). Although carrying a
predisposition to disease (symbolized by orange colored child and
adolescent), such individuals can stay healthy in the absence of trauma and
stress (upper panel). Early life adversity (red flash) can elicit epigenetic
programing of stress genes via DNA (de-)methylation (symbolized by red
lollipops on DNA double helix) leading to altered expression. These
alterations confer an increased vulnerability to later on trauma and stress
and ultimately result in manifestation of PTSD and depression (middle
panel). Genetic mutations (orange segment of the DNA double helix) can
serve as a substrate for epigenetic programing in response to early trauma
and stress (red flash) via DNA (de-)methylation (symbolized by red lollipops
on red segment of DNA double helix). This pre-activation can result in PTSD
and depression following anew exposure to trauma and stress (lower
panel).
plus-maze and reduced exploration time of novel objects) this
alteration associated with sex-specific differences in Avp expres-
sion. In this respect male but not female mice showed increases in
Avp immunoreactivity in magnocellular neurons of the PVN and
the lateral hypothalamus.
Sex differences in response to early-life adversity are not lim-
ited to Avp but extend to the receptor level. Adult rats that
were reared by high licking and grooming mothers showed
increased Avp V1a receptor binding in the central nucleus of the
amygdala (113).
A recent study in human strengthens the importance of sex
differences in AVP expression and suggests possible therapeutic
consequences (114). PTSD is associated with problems in intimate
relationships, partly due to impaired social cognition. Attention
to partner expressions of anger was investigated as an indicator
of distress and need for affiliative behaviors to repair the rela-
tionship bond. AVP administration enhanced men’s attentional
engagement with their partners’ expressions of anger and allevi-
ated the negative impact of PTSD on this social cognitive process.
Moreover, men’s morning urinary AVP levels were negatively cor-
related with their PTSD severity. In contrast, no such effects were
detected among women or for attention to unfamiliar men’s or
women’s anger expressions.
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Collectively, early-life adversity preferentially programs the
expression of hypothalamic Avp and its receptor in male rodents.
Moreover, deficits in social cognition in male PTSD patients are
improved following AVP administration.
EPIGENETIC PROGRAMING OF Avp
Maternal separation (3 h per day from postnatal day P 1–10)
has been used to study early-life stress in male mice. Consistent
with previous studies, adult mice displayed a hyperactive HPA
axis characterized by corticosterone hypersecretion under resting
conditions and following application of an acute stressor. These
findings associated with enhanced immobility in the forced swim
test and memory deficits in an inhibitory avoidance task (115).
Whereas hypothalamic Crh mRNA expression was not affected
by early-life stress, the paradigm resulted in a sustained upregula-
tion of Avp. This response was confined to the PVNh coordinating
the stress response whereas Avp expression in the supraoptic
hypothalamic nucleus which controls fluid homeostasis remained
unaffected. Increased Avp expression correlated with reduced lev-
els of DNA methylation at multiple CpG residues at a down-
stream enhancer region which serves to fine-tune gene expression.
Hypomethylation evolved gradually in response to maternal sepa-
ration to reach a maximum at 6 weeks. Thereafter, changes in DNA
methylation declined slowly but were still detectable after 1 year
(115).
Hypomethylation localized to high affinity DNA-binding sites
for the methyl-CpG-binding protein Mecp2. This epigenetic
reader serves as a scaffold for the assembly of DNMTs and his-
tone deacetylases which can rewrite epigenetic marks to induce
gene silencing (86, 116). Hypomethylation in 6-week-old early-
life stress treated mice reduced Mecp2 binding at theAvp enhancer
and consequently promoted increased gene expression.
Early-life stress treated mice showed, however, no signs of
hypomethylation directly after termination of the stressor (post-
natal day 10) although Avp expression was robustly increased. This
finding indicated that stress signals unrelated to DNA methylation
appear to control binding of Mecp2 at earlier stages. In support of
this concept, depolarization-dependent Ca2+ influx and activation
of calmodulin kinases has been shown to cause Mecp2 phos-
phorylation. This event impairs Mecp2 DNA binding and dere-
presses target genes (115). In accord with this hypothesis, early-life
stress treated mice showed increased Mecp2 phosphorylation in
parvocellular Avp-expressing neurons at postnatal day 10.
Taken together, these results suggest a stepwise mode for epi-
genetic programing of Avp. Initially, early-life stress leads to phos-
phorylation of the epigenetic reader Mecp2. This modification
favors dissociation from theAvp enhancer and promotes increased
expression. Moreover, due the absence of Mecp2, epigenetic writ-
ers like DNMTs and histone deacetylases loose their docking sites
and will fall short to maintain DNA methylation. As a result
Avp hypomethylation will gradually evolve and leave a persistent
memory trace of the early-stress event encoding an altered stress
regulation.
This stepwise mode of epigenetic programing of Avp in
response to early trauma involves the transition from stress-
induced posttranslational modifications (so called soft-wiring) to
stable DNA modifications (so called hard wiring). Although there
are so far no related studies in humans, we want to point out that
changes following from exposure to early life adversity appear ini-
tially reversible. They might, however, solidify over time or upon
re-exposure to stress. In this respect, early interventions such as
improvements in parenting and the social environment might
delay or protect individuals exposed to early trauma to develop
disease at later stages.
EXPERIENCE-DEPENDENT PROGRAMING OF GR
Experience-dependent programing of the HPA axis also applies to
negative feedback regulators like the GR. Enhanced maternal care
during the first 10 days of life (95) and daily short (15 min) peri-
ods of maternal separation during the first postnatal week (98, 99)
increase hippocampal GR expression in adult rodents. This event
leads to decreased hypothalamic Crh expression and an attenuated
response upon acute stress exposure over life span (117, 118).
On the other hand, extended periods of maternal separation
(up to 4.5 h per day) change the direction of GR expression later
in life and manifest with reduced expression of hippocampal GR
in rodents. Consequently, negative feedback regulation of the HPA
axis is impaired as evidenced by elevated levels of ACTH and corti-
costerone in adulthood (98). These early life dependent alterations
in GR expression can be reversed by housing up-growing animals
under an enriched environment which normalizes GR expression,
behavioral, and memory performance (119).
EPIGENETIC PROGRAMING OF GR
The molecular foundations of epigenetic programing of the GR
in response to early life care have been discovered by Meaney and
Szyf in a series of elegant studies (120) [reviewed in (42, 121)].
Briefly, natural variations in maternal care can stimulate to differ-
ent degree serotonin turnover in the hippocampus of 6-day-old rat
pups, where GR expression is site-specifically increased. Follow-
ing binding to its receptor, serotonin activates via protein kinase
A the expression of the immediate early gene NGFI-A encoding
a zinc finger transcription factor. NGFI-A protein binds in turn
to its recognition site at exon 17 of the proximal GR promoter to
enhance transcription.
How do these events establish a lasting record of maternal care?
Multiple untranslated first exons of the proximal GR promoter are
transcribed as a result of the associated promoter activity and are
spliced on the common second exon to give rise to the same GR
protein. The major part of the proximal GR promoter, including
most alternative exons and the hippocampus-specific exon 17, are
contained within a CGI. As alluded above, CGIs can be subject to
DNA methylation and serve to control gene expression potential.
In this respect the offspring from high-care taking mothers showed
decreased CpG methylation at the NGFI-A binding site when com-
pared to offspring of the same age from low-care taking mothers.
These differences developed in the first postnatal week concur-
rent with differences in maternal care and its effect on NGFI-A
expression (122). Differences in maternal care disappeared after
the first postnatal week and consequently adult rats did not
diverge anymore in hippocampal NGF-IA expression. Maintained
hypomethylation left, however, an enduring memory trace of the
postnatal environment and underpinned increased GR expression
restraining HPA-axis activity in response to future stressors.
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Epigenetic programing of GR occurs also in adult mice.
Chronic and acute stress during adulthood induces changes in
the methylation level of the GR promoter at exon 17 in the pitu-
itary and adrenal gland whereas brain tissues remained unaffected
(123). This result corroborates above findings from Crh and sug-
gests that epigenetic programing is tissue-specific dependent on
developmental stage.
The hypothesis that early life adversity in humans induces sim-
ilarly epigenetic programing of hippocampal GR expression has
been addressed by postmortem brain analysis from suicide victims
(124). The documented histories of childhood adversities included
severe sexual or physical abuse and neglect. Interestingly, total GR
and exon 1F (the human homolog of rat exon 17) expression in
the hippocampus was reduced in suicide victims with a history
of abuse, but not in those without such a history or in control
subjects. These results indicate that GR expression associated with
early life adversity rather than with circumstances of life leading
the way to suicide. These results agree with above findings from
rodents that epigenetic programing of GR depends on the develop-
mental context. Together, these studies in human and rat support
the concept of a DNA-based memory that underpins the lasting
effects of early life adversity.
Does then prenatal adversity also cause epigenetic programing
of GR? Children whose mothers’ were exposed to enduring stress
during pregnancy (i.e., depression, anxiety, death of a relative, or
marital discord) suffer from increased rates of psychological and
behavioral disorders as adults (103). Hereby, the respective off-
spring frequently shows signs of HPA-axis deregulation similar
to those detected in their depressed mothers (125). In support
of above consideration, maternal depression in the third trimester
led to an increased neonatal methylation of the presumed NGFI-A
DNA-binding site situated at exon 1F in cord blood cells. Addition-
ally, newborn methylation at nucleotide residue CpG3 associated
with an enhanced cortisol response to an experimental stressor at
3 months of age (126). These data suggest that gestational depres-
sion can elicit epigenetic programing of peripheral and possibly
central GR expression in neonates which might result in altered
HPA-axis responsiveness in small children.
How long does epigenetic programing of neonate GR in
response to maternal depression last? In a further study exon 1F
methylation was measured in a group of children in the range
from 10 to 19 years and in their respective mothers. Retrospec-
tive psychological evaluations were used to identify those mothers
who had been exposed to physical or psychological abuse before,
during, or after pregnancy. Exon 1F methylation was increased
in adolescent children whose mothers’ had experienced intimate
partner violence during pregnancy (127). In contrast, adolescent
exon 1F methylation was unaffected in case of prenatal or post-
natal maternal abuse pointing to the critical role of gestational
stress in epigenetic programing of fetal GR. Moreover, none of
the respective mothers presented with altered exon 1F methyla-
tion in peripheral blood mononuclear cells (PBMC) suggesting
that epigenetic programing of GR is confined to few sensitive time
windows during development.
In further support of this idea, individuals suffering from major
depression or borderline personality disorders exhibit increased
exon 1F methylation in PBMC. Changes in DNA methylation were
more prominent in the latter group and correlated in either with
a history of child abuse, its severity, and the exposure to multiple
types of maltreatment (128). Interestingly, healthy adults with a
history of childhood adversity (maltreatment, poor quality par-
enting, loss of parents) show as well increased CpG3 methylation
at exon 1F in PMBC and an attenuated cortisol response to the
dexamethasone/CRH test (129). This finding corroborates that
variation in parenting experiences in humans can bring about
epigenetic programing of GR and HPA-axis deregulation without
clinical manifestation. In this respect, additional stressors appear
necessary to give rise to diseases such as depression and PTSD
(Figure 5). Collectively, changes in exon 1F methylation seem to
fulfill the criteria of an epigenetic risk marker to identify persons
at future risk. Follow-up studies are needed to test this hypothesis
and to explore exon 1F methylation as a potential biomarker for
treatment response and relapse upon disease’s manifestation.
GENE-ENVIRONMENT INTERACTIONS IN PTSD
Since the days of Garrod (130), medical research has been puzzled
by the fact that the etiology of most common diseases depends
not only on discrete genetic and environmental causes but also
on the interaction between the two. Separate estimates on the
contributions of genes and the environment to a disease without
considering their interactions will only incorrectly describe the
proportion of the disease (i.e., the population attributable risk)
that is explained by genes, the environment, and their joint effects
(Figure 5). A landmark discovery in this respect was the finding
that the association of a polymorphism in the promoter region of
the serotonin transporter gene (SLC6A4, commonly known as 5-
HTT) with depression is influenced by stressful life events (131).
Following on the concept of gene-environment interaction has
been increasingly applied to quantitative epidemiological stud-
ies, although the nature of the mechanism(s) underpinning such
interplay remained so far elusive. Two recent studies on gene-
environment interactions in PTSD shed light on the potential
contribution of epigenetic mechanisms as a mediator between risk
alleles and early life events.
The neuropeptide PACAP (pituitary adenylate cyclase activat-
ing polypeptide) binds to the G-protein coupled receptor PAC1
(132) and is involved in the brain’s response to stress. The PAC1
protein is encoded by the gene ADCYAP1R1 that has been recently
suggested to influence in a sex-specific manner whether an indi-
vidual will develop PTSD (133). A cohort of urban primary-care
patients who had been exposed to severe trauma (child maltreat-
ment, a serious accident or attack with a weapon) showed a positive
correlation between peripheral blood levels of PACAP and the
extent of posttraumatic stress syndromes, but only in women.
High PACAP values correlated with physiological measures of
the acoustic startle reflex which has been previously associated
with PTSD. Moreover, in a translational animal model the mRNA
expression of PAC1 was increased in the amygdala of adult mice
following classical fear conditioning and as a function of estrogen
exposure.
Notably, a common genetic variant (rs267735) in ADCYAP1R1
associated with PTSD. This finding was replicated in a second
cohort of patients exposed to trauma, once again only in women
(133). Differential DNA methylation of ADCYAP1R1 associated
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with PTSD symptoms and included the variant rs267735 which
maps to a predicted estrogen response element. In support of a
regulatory role of this genetic variant, postmortem analysis of
female brains evidenced differential expression of PAC1 mRNA
as function of the underlying genotype.
Together, these findings offer insight into the question of why
women are more likely than men to develop PTSD and suggest
that traumatic stress can leave an enduring memory trace on
the epigenome by DNA methylation at regulatory polymorphic
sites of genes that participate in the stress response. The reg-
ulatory site at ADCYAP1R1 maps to an ERE which undergoes
DNA methylation in response to early trauma and thus consti-
tutes an epigenetic risk factor for the later development of PTSD
in women.
Similarly, a recent study suggested that a polymorphism in the
FK506 binding protein 5 gene (FKBP5) can serve as a substrate for
early trauma-dependent epigenetic marking to increase the risk
for PTSD (134). FKBP5 controls GR function by reducing ligand
binding and translocation of the receptor complex to the nucleus
(135). Hereby, FKBP5 forms part of a negative, intracellular, ultra-
short feedback loop due to GR-dependent transactivation at a
glucocorticoid response element (GRE) situated in intron 2. A
polymorphism identified in this intron gave rise to a potential
TATA element supporting the assembly of the transcriptional
machinery. Adults who were homozygous or heterozygous for the
A (risk) allele at this polymorphism rather than the G (protective)
allele were more likely to suffer from PTSD – provided they had
experienced abuse as children. The risk allele conferred an altered
chromatin structure and increased transcription of FKBP5, hence
strengthening the negative feedback loop that attenuated GR activ-
ity. Impaired GR function, in turn increases the hormonal response
to stress.
How do traumatic experiences then act together with the risk
allele in PTSD? Traumatic experiences lead to activation of the
GR which is known to initiate changes in DNA methylation (136).
Notably, CpG residues in intron 7 of FKBP5 – flanking a predicted
GRE – were less methylated in risk allele carriers with a history
of childhood abuse compared to those without a history of early
trauma or traumatized patients without the risk allele.
In a translational in vitro model of early-life stress, treat-
ment of hippocampal progenitor cells with dexamethasone elicited
demethylation of intron 7 during proliferation and differentiation.
The decline in methylation persisted over 20 days in steroid-
free culture compatible with the idea of an enduring epige-
netic mark. Furthermore, demethylation in intron 7 of FKBP5
increased FKBP5 expression, GR resistance, and led to corre-
sponding changes in the expression of downstream genes in PTSD
patients harboring the risk allele. In contrast, risk carriers exposed
to trauma in adulthood showed maintained DNA methylation
at intron 7 suggesting that epigenetic programing of FKBP5 is
confined to a critical time window of hippocampal cell develop-
ment. Compatible with this view, demethylation at intron 7 in
hippocampal neuronal progenitor cells occurred only during the
proliferative phase (134).
Consistent with the role of glucocorticoids in controlling Fkbp5
expression via DNA methylation, treatment of adolescent mice
with corticosterone across 4 weeks enhanced gene expression in
the hippocampus, hypothalamus, and peripheral blood cells (137,
138). This was accompanied by demethylation at intron 5 and
1 in brain tissues and peripheral blood cells, respectively. Inter-
estingly, either intron includes a GRE binding side. Moreover,
treatment doses correlated with Fkbp5 expression and demethyla-
tion at intron 1 indicating that intron 1 demethylation could serve
as a biomarker for prior glucocorticoid load (138).
Together, these findings support the concept that exposure of
children carrying the risk allele to stress can elicit enduring epi-
genetic changes in FKBP5 gene expression predisposing them to
stress-associated disorders such as PTSD (Figure 5).
CONCLUSION
More than 100 years have passed since Sigmund Freud described
the influence of early traumatic experiences on later mental health.
Numerous epidemiological, clinical, and translational studies have
corroborated the powerful role of early life adversity for the devel-
opment of depression and PTSD. During sensitive windows of
development, adversity can lead to enduring (mal-) programing
of the stress system which constitutes an important risk factor for
later disease.
Epigenetic mechanisms mediate the dialog between our genes
and the environment and can elicit lasting changes in gene expres-
sion potential. Experience-dependent epigenetic programing of
stress genes is increasingly recognized as an important pathway in
the deregulation of stress systems in rodents and patients. Such
programing can confer an enhanced risk on disease development
upon re-exposure to trauma or stress (Figure 5). Epigenetic pro-
graming is, however, not deterministic. In translational models,
an enriched environment can attenuate the effects of epigenetic
programing. Epigenetic modifications appear amenable across all
chapters in one’s life and thus offer great opportunities for timely
interventions comprising pharmaceutical and psychotherapeutic
treatments.
Nearly twice as much women are affected by stress-related
mood disorders compared to men. The HPA axis, the central medi-
ator of the stress response, shows clear sex differences which seem
to impact on the prevalence and course of stress-related diseases.
Further clinical and translational studies focusing on sex differ-
ences in epigenetic programing of HPA-axis activity and brain
functions in response to traumatic and social experiences can
advance our insight into the sex-bias of PTSD and depression.
Epigenetic biomarkers (i.e., GR and FKBP5 in PBMS) in popu-
lations at risks appear promising to inform about previous stress
exposure and require further clinical investigations.
With the decoding of the human genome at the turn of the
millenium, medical research pinned its hope, above all, on the
identification of gene variants coming along with an elevated risk
of contracting a disease (Figure 5). However, it has become clear
that genetic factors and environmental influences are not inde-
pendent of each other and that acquired pieces of information
deliver the instruction how to interpret the genetic blueprint.
Whether or not a genetic predisposition manifests as PTSD or
depression then seems to depend on how genes and environ-
ment conspire. Epigenetic programing in response to trauma or
stress can be modified by genetic variation in the underlying sub-
strates. Hereby, silent variations are switched into epigenetic risk
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factors for PTSD or depression in response to additional adversities
(Figure 5). Further studies are needed to address tissue-specificity
of experience-dependent programing of genetic variants to dis-
tinguish between roles as biomarker, reflecting humoral changes
in response to trauma versus roles as epigenetic risk factor driving
disease development.
Taken together, epigenetic mechanisms play an important role
in experience-dependent programing of stress genes and their
genetic variants. Moreover, epigenetic biomarkers encoding pre-
vious trauma and stress history might guide early therapeutic
interventions and risk management in PTSD and depression on a
long-term perspective.
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